Monod Bio Receives Award to Develop a New Diagnostic Test for Preeclampsia using AI-designed Proteins

$750,000 grant will accelerate the development of a point-of-care diagnostic to improve maternal health outcomes in low-resource settings SEATTLE, Oct. 15, 2025 /PRNewswire/ -- Monod Bio, a biotechnology company utilizing AI-powered de novo protein design for diagnostic and research...